<VariationArchive VariationID="1698387" VariationName="NM_000146.4(FTL):c.460dup (p.Arg154fs)" VariationType="Duplication" Accession="VCV001698387" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-29" DateCreated="2022-07-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1690766" VariationID="1698387">
      <GeneList>
        <Gene Symbol="FTL" FullName="ferritin light chain" GeneID="2512" HGNC_ID="HGNC:3999" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="48965309" stop="48966879" display_start="48965309" display_stop="48966879" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="49468565" stop="49470135" display_start="49468565" display_stop="49470135" Strand="+" />
          </Location>
          <OMIM>134790</OMIM>
          <Haploinsufficiency last_evaluated="2013-08-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FTL">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-08-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FTL">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000146.4(FTL):c.460dup (p.Arg154fs)</Name>
      <CanonicalSPDI>NC_000019.10:48966666:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="48966666" stop="48966667" display_start="48966666" display_stop="48966667" variantLength="1" positionVCF="48966666" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="49469923" stop="49469924" display_start="49469923" display_stop="49469924" variantLength="1" positionVCF="49469923" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>R154fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.48966667dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.48966667dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000146.4" sequenceAccession="NM_000146" sequenceVersion="4" change="c.460dup" MANESelect="true">
            <Expression>NM_000146.4:c.460dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000137.2" sequenceAccession="NP_000137" sequenceVersion="2" change="p.Arg154fs">
            <Expression>NP_000137.2:p.Arg154fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.49469924dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.49469924dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008152.1" sequenceAccession="NG_008152" sequenceVersion="1" change="g.6359dup">
            <Expression>NG_008152.1:g.6359dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012923.1" sequenceAccession="NG_012923" sequenceVersion="1" change="g.31687dup">
            <Expression>NG_012923.1:g.31687dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="134790.0010" DB="OMIM" />
        <XRef Type="rs" ID="2122436083" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000146.4(FTL):c.460dup (p.Arg154fs) AND Neuroferritinopathy" Accession="RCV002269810" Version="3">
        <ClassifiedConditionList TraitSetID="5415">
          <ClassifiedCondition DB="MedGen" ID="C1853578">Neuroferritinopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-06-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000146.4(FTL):c.460dup (p.Arg154fs) AND multiple conditions" Accession="RCV003096106" Version="2">
        <ClassifiedConditionList TraitSetID="43504">
          <ClassifiedCondition DB="MedGen" ID="C1833213">Hereditary hyperferritinemia with congenital cataracts</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1853578">Neuroferritinopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-09" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2022-07-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11438811</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12746423</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18854324</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25832658</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301320</ID>
          <ID Source="BookShelf">NBK1141</ID>
        </Citation>
        <DescriptionHistory Dated="2022-09-14">
          <Description>not provided</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-09-14">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="43504" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3088" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neurodegeneration with brain iron accumulation 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BASAL GANGLIA DISEASE, ADULT-ONSET</ElementValue>
                <XRef Type="MIM" ID="606159" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neuroferritinopathy</ElementValue>
                <XRef ID="156901" DB="GeneTests" />
                <XRef ID="Neuroferritinopathy/5169" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011638" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA3</ElementValue>
                <XRef Type="MIM" ID="606159" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10686" />
                <XRef ID="10686" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Neuroferritinopathy is an adult-onset progressive movement disorder characterized by chorea or dystonia and speech and swallowing deficits. The movement disorder typically affects one or two limbs and progresses to become more generalized within 20 years of disease onset. When present, asymmetry in the movement abnormalities remains throughout the course of the disorder. Most individuals develop a characteristic orofacial action-specific dystonia related to speech that leads to dysarthrophonia. Frontalis overactivity and orolingual dyskinesia are common. Cognitive deficits and behavioral issues become major problems with time.</Attribute>
                <XRef ID="NBK1141" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301320</ID>
                <ID Source="BookShelf">NBK1141</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <XRef ID="157846" DB="Orphanet" />
              <XRef ID="C1853578" DB="MedGen" />
              <XRef ID="MONDO:0011638" DB="MONDO" />
              <XRef Type="MIM" ID="606159" DB="OMIM" />
            </Trait>
            <Trait ID="2178" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary hyperferritinemia with congenital cataracts</ElementValue>
                <XRef ID="MONDO:0010952" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERFERRITINEMIA WITH OR WITHOUT CATARACT</ElementValue>
                <XRef Type="MIM" ID="600886" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134790.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134790.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134790.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134790.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134790.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134790.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134790.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134790.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134790.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134790.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134790.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134790.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134790.0017" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperferritinemia cataract syndrome</ElementValue>
                <XRef ID="Hyperferritinemia+cataract+syndrome/3553" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary hyperferritinemia cataract syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bonneau-Beaumont syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HHCS</ElementValue>
                <XRef Type="MIM" ID="600886" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2806" />
                <XRef ID="2806" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="163" DB="Orphanet" />
              <XRef ID="C1833213" DB="MedGen" />
              <XRef ID="MONDO:0010952" DB="MONDO" />
              <XRef Type="MIM" ID="600886" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5415" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3088" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neurodegeneration with brain iron accumulation 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BASAL GANGLIA DISEASE, ADULT-ONSET</ElementValue>
                <XRef Type="MIM" ID="606159" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neuroferritinopathy</ElementValue>
                <XRef ID="156901" DB="GeneTests" />
                <XRef ID="Neuroferritinopathy/5169" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011638" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA3</ElementValue>
                <XRef Type="MIM" ID="606159" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10686" />
                <XRef ID="10686" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Neuroferritinopathy is an adult-onset progressive movement disorder characterized by chorea or dystonia and speech and swallowing deficits. The movement disorder typically affects one or two limbs and progresses to become more generalized within 20 years of disease onset. When present, asymmetry in the movement abnormalities remains throughout the course of the disorder. Most individuals develop a characteristic orofacial action-specific dystonia related to speech that leads to dysarthrophonia. Frontalis overactivity and orolingual dyskinesia are common. Cognitive deficits and behavioral issues become major problems with time.</Attribute>
                <XRef ID="NBK1141" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301320</ID>
                <ID Source="BookShelf">NBK1141</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <XRef ID="157846" DB="Orphanet" />
              <XRef ID="C1853578" DB="MedGen" />
              <XRef ID="MONDO:0011638" DB="MONDO" />
              <XRef Type="MIM" ID="606159" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38226" SubmissionDate="2017-07-19" DateLastUpdated="2017-07-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="134790.0010_NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3" title="FTL, 1-BP INS, 460A_NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3" />
        <ClinVarAccession Accession="SCV000038226" DateUpdated="2017-07-22" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a large family segregating an autosomal dominant basal ganglia disease, known as neurodegeneration with brain iron accumulation-3 or neuroferritinopathy (NBIA3; 606159), and in 5 additional individuals with similar manifestations, Curtis et al. (2001) identified an adenine insertion after nucleotide 460 of the FTL gene, which was predicted to alter the 22 C-terminal residues of the gene product and extend the chain by 4 additional residues. The mutation is predicted to disrupt the end of the D helix, the DE loop, and the E helix. Residues of the E helix form hydrophobic channels in the ferritin 4-fold axes of symmetry, are highly conserved, and are essential for iron core formation. This mutation was not identified in over 300 Cumbrian controls.</Attribute>
              <Citation>
                <ID Source="PubMed">11438811</ID>
              </Citation>
              <XRef DB="OMIM" ID="606159" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Although Chinnery et al. (2003) reported that they identified the 460insA mutation in affected members of a French family with neuroferritinopathy, Devos et al. (2009) concluded that the mutation in that family was actually a 458insA change (134790.0016). Both mutations create the same EcoN1 restriction site.</Attribute>
              <Citation>
                <ID Source="PubMed">12746423</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">18854324</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTL" />
          </GeneList>
          <Name>FTL, 1-BP INS, 460A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 460A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="134790.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4996367" SubmissionDate="2022-07-27" DateLastUpdated="2022-10-01" DateCreated="2022-07-29">
        <ClinVarSubmissionID localKey="NM_000146.3:c.460dupA|OMIM:606159" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV002553191" DateUpdated="2022-10-01" DateCreated="2022-07-29" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1141</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000146.3:c.460dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1853578" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>SUB11864799</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6132957" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4957618|MedGen:C1853578;C1833213" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003443932" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11438811</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25832658</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1698387). This frameshift has been observed in individuals with neurodegeneration with brain iron accumulation (PMID: 11438811, 25832658). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the FTL gene (p.Arg154Lysfs*27). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 22 amino acid(s) of the FTL protein and extend the protein by 4 additional amino acid residues.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.49469923_49469924insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1853578" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1833213" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6132957" TraitType="Disease" MappingType="XRef" MappingValue="C1833213" MappingRef="MedGen">
        <MedGen CUI="C1833213" Name="Hereditary hyperferritinemia with congenital cataracts" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6132957" TraitType="Disease" MappingType="XRef" MappingValue="C1853578" MappingRef="MedGen">
        <MedGen CUI="C1853578" Name="Neuroferritinopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4996367" TraitType="Disease" MappingType="XRef" MappingValue="C1853578" MappingRef="MedGen">
        <MedGen CUI="C1853578" Name="Neuroferritinopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="38226" TraitType="Disease" MappingType="Name" MappingValue="NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3" MappingRef="Preferred">
        <MedGen CUI="C1853578" Name="Neuroferritinopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

